| Literature DB >> 31721710 |
Adrian Bartoszek1, Jakub Fichna1, Aleksandra Tarasiuk1, Agata Binienda1, Adam Fabisiak1,2, Julia B Krajewska1, Paula Mosińska1, Karolina Niewinna1, Maciej Salaga1.
Abstract
Colorectal cancer (CRC) is one of the most common cancers worldwide. In developed countries, its mortality remains high, yet the prevalence has established owing to effective screening programs; however due to the westernization of lifestyle, the incidences in many other countries have increased. Although the treatment of CRC has improved in the last few years, the side effects of these approaches cannot be neglected. Recently, members of the family of free fatty acid receptors (FFARs) have become attractive pharmacological targets in many diseases, including asthma; studies also point to their role in carcinogenesis. Here, we discuss current knowledge and future directions in FFAR research related to CRC. Contradictory results of FFARs modulation may derive from the pleiotropic effects of FFAR ligands, receptor distribution and different signal transduction. Hence, we indicate directions of further studies to fully use the potential of FFARs in CRC. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: Free fatty acids receptors; G protein-coupled receptors; cancer; colorectal cancer; diet; fatty acids
Year: 2020 PMID: 31721710 DOI: 10.2174/1389450120666191112141901
Source DB: PubMed Journal: Curr Drug Targets ISSN: 1389-4501 Impact factor: 3.465